Intraoperative and Postoperative Intraocular Lens Opacifications: Analysis of 42545 Cases

Table 1

Characteristics of the patients with postoperative IOL opacification.

Case	IOL type	IOL serial number	Sex/age (Y)	Date of implantation	Time interval (Mo)^#	BCVA		Associated general conditions
						Before	After
1	860UV	—	M/68	26/2/2017	18	20/25	20/200	—
2	860UV	O-28416001-029	M/75	09/05/2017	20	20/40	20/63	—
3	860UV	O-10717012-022	M/76	26/12/2017	23	20/25	20/50	—
4	860UV	—	M/73	09/02/2017	48	20/25	20/32	—
5	L-312	91310521013	M/47	01/12/2015	56	20/25	20/200	Diabetes
6	860UV	O-04717025-033	F/73	13/11/2017	24	20/32	20/125	Hypertension, cardiopathy
7	860UV	O-21116050-006	F/76	16/01/2017	12	20/32	20/200	—
8	860UV	O-04817001-005	F/79	13/07/2017	27	20/25	20/50	Hypertension
9	L-312	91307941002	F/71	08/10/2015	59	20/32	20/50	Diabetes
	L-312	91307941004	F/71	26/09/2015	58	20/32	20/100	Renal insufficiency

IOL = intraocular lens; ^#time interval between implantation and diagnosis of opacification. Before, before IOL opacification; after, after IOL opacification.